National Health Investors is a reit - healthcare facilities business based in the US. National Health Investors shares (NHI) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $77.06 – a decrease of 2.01% over the previous week. National Health Investors employs 26 staff and has a trailing 12-month revenue of around $327 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $77.06 |
|---|---|
| 52-week range | $45.93 - $85.21 |
| 50-day moving average | $80.06 |
| 200-day moving average | $66.66 |
| Wall St. target price | $85.86 |
| PE ratio | 26.2109 |
| Dividend yield | $3.6 (4.71%) |
| Earnings per share (TTM) | $2.94 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $77.06 from 2024-10-15
| 1 week (2024-10-10) | -2.01% |
|---|---|
| 1 month (2024-09-17) | -9.06% |
| 3 months (2024-07-17) | 5.16% |
| 6 months (2024-04-17) | 29.40% |
| 1 year (2023-10-17) | 52.62% |
|---|---|
| 2 years (2022-10-17) | 42.10% |
| 3 years (2021-10-15) | 36.39% |
| 5 years (2019-10-17) | 5.08% |
Valuing National Health Investors stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of National Health Investors's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
National Health Investors's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 26x. In other words, National Health Investors shares trade at around 26x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
National Health Investors's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.99. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into National Health Investors's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
National Health Investors's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $253.4 million.
The EBITDA is a measure of a National Health Investors's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $327 million |
|---|---|
| Operating margin TTM | 62.55% |
| Gross profit TTM | $269 million |
| Return on assets TTM | 4.62% |
| Return on equity TTM | 9.9% |
| Profit margin | 39.02% |
| Book value | $33.73 |
| Market Capitalization | $3.3 billion |
TTM: trailing 12 months
Dividend payout ratio: 122.45% of net profits
Recently National Health Investors has paid out, on average, around 122.45% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.71% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), National Health Investors shareholders could enjoy a 4.71% return on their shares, in the form of dividend payments. In National Health Investors's case, that would currently equate to about $3.6 per share.
National Health Investors's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
National Health Investors's most recent dividend payout was on 31 October 2024. The latest dividend was paid out to all shareholders who bought their shares by 26 September 2024 (the "ex-dividend date").
Over the last 12 months, National Health Investors's shares have ranged in value from as little as $45.928 up to $85.2076. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while National Health Investors's is 1.065. This would suggest that National Health Investors's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals. .
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
These are the stocks to buy when you don’t have much to spend.
Explore the best bonuses for opening a new brokerage account.
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
What you need to know about investing in the leading indicator for the overall US stock market.
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Read our beginner’s guide to trading options in the US.